Hepatitis C in healthcare personnel: follow-up analysis of treatments with direct-acting antiviral agents

Table 3 Univariate and multivariate analysis regarding SVR12 (n = 305)

Variable	Missing values	n	OR¹ (95% CI) univariate	p-value	OR² (95% CI) multivariate	p-Value
Cirrhosis	51	254	0.07 (0.01–0.62)	0.02	0.05 (0.01–0.52)	0.01
(no/yes)		(184/70)
Treatment	39	266	3.39 (0.56-20.71)	0.19	–	–
(naive/experienced)		(83/183)
RWA	13	292	0.18 (0.03-1.01)	0.05	–	–
(< 50%/≥50%)		(212/80)
Gender	0	305	0.06 (0.01-0.49)	0.01	–	–
(women/men)		(234/71)
Age^a	0	305	0.99 (0.91-1.08)	0.89	1.06 (0.94-1.19)	0.36

¹ Univariate analysis
² Multivariate analysis with adjusted OR
^a as continuous variable
OR Odds ratio, CI Confidence interval, SVR12 Sustained virological response 12 weeks after therapy, RWA Reduced Work Ability

ISSN: 1745-6673